Pressure Biosciences (PBIO) 0.3590 $PBIO Pressure

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pressure Biosciences (PBIO) 0.3590 $PBIO

Pressure BioSciences Selected to Present at Cavendish Global Health Impact Forum
PR Newswire - Fri May 08, 7:15AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" , a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT" -based instruments and consumables to the worldwide life sciences industry, today announced it has been selected to present at the Cavendish Global Health Impact Forum taking place May 10th to May 14th in La Jolla, California. Mr. Richard T. Schumacher, Founder and CEO of PBI will present a corporate overview on Monday afternoon, May 11, 2015. Mr. Schumacher plans to present an update on several of PBI's key development programs, including PCT-based sample preparation methods for next generation DNA sequencing; improved extraction of chemical toxins and carcinogens from environmental samples; improved detection of DNA in forensic samples, including rape kits; and the advantages of the PCT platform in drug discovery and design, cancer detection, and in the analysis of microbial communities in soil.

Data from Recently Published Studies Provide Strong Support for Current and Future Applications of Pressure BioSciences' PCT Platform
PR Newswire - Mon May 04, 8:31AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" , a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT" -based instruments and consumables to the worldwide life sciences industry, today announced the publication of three important articles in scientific journals by key opinion leaders in proteomics and genomics. The Company believes the articles highlight the clear advantages its patented PCT platform offers research scientists working in the areas of drug discovery and design, cancer detection, and the analysis of microorganism populations in soil. The Company also believes that the data offer compelling reasons why its PCT-based instruments and consumables may soon become a "need-to-have" tool in these and other areas of the life sciences.

Novel Environmental Epidemiology Application for Pressure BioSciences' Barozyme HT48 High-throughput System Developed
PR Newswire - Thu Apr 30, 8:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" , a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT" -based instruments and consumables to the worldwide life sciences industry, today announced that Dr. William Funk, Assistant Professor in Preventive Medicine-Cancer Epidemiology and Prevention at the Northwestern University ("NU" Feinberg School of Medicine, and his postdoctoral fellow, Dr. Daniel Ladror, presented a novel application for the Company's new Barozyme HT48 high-throughput PCT-based System (the "HT48 System" in environmental epidemiology. The presentations were made at the 2015 Pittcon Conference & Expo (largest annual conference & exposition for laboratory science) and at NU's 11th Annual Lewis Landsberg Research Day.

Pressure BioSciences to Collaborate with Southern University at New Orleans on Improving and Extending the Use of PBI's PCT Platform for the Detection of DNA in Forensic Samples
PR Newswire - Tue Apr 14, 6:21AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced it has entered into a Collaboration Agreement with Southern University at New Orleans (SUNO) to focus on improving and extending the applications of the Company's unique and patented pressure cycling technology (PCT) platform for the detection of DNA in forensic samples. The program will be under the direction of Dr. Pam Marshall, Interim Director, Forensic Science Program and Assistant Professor, Department of Natural Sciences at SUNO.

Pressure BioSciences, Inc. Reports Fiscal Year 2014 Financial Results and Provides Business Update
PR Newswire - Wed Apr 01, 10:57AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the fiscal year ended December 31, 2014, provided a business update, and offered limited guidance for FY2015.

Pressure BioSciences Announces the Release of PCT-HD, "The Next Generation Protein Preparation System"
PR Newswire - Thu Mar 12, 10:03AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" , a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT" -based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system. The Company plans to highlight PCT-HD at the annual meeting of the US Human Proteomic Organization ("US HUPO" , being held March 15-18 in Tempe, Arizona. The Company added that key advantages of the PCT-HD System in the application of biomarker discovery will be discussed in two separate presentations during the conference.

Pressure BioSciences Inc., ("PBI" (OTCQB: PBIO), Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference
ACCESSWIRE - Tue Mar 10, 9:12AM CDT
EASTON, MA and NEW YORK, NY / ACCESSWIRE / March 10, 2015 / Pressure BioSciences Inc., ("PBI" or the "Company" (OTCQB: PBIO), a company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT" , granted an exclusive interview at the recent FSXinterlinked Investment Conference, held in New Orleans.

Pressure BioSciences Receives First Purchase Order for its Barozyme HT48 High-throughput System
PR Newswire - Tue Feb 10, 6:44AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" , a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT" -based instruments and consumables to the worldwide life sciences industry, today announced the receipt of the first purchase order for its new Barozyme HT48 High-throughput System. The Company also announced the receipt of a request for a quotation for the possible purchase of a second Barozyme HT48 System; the request came from an existing European customer.

Pressure BioSciences, Inc. to Present at the SeeThruEquity Winter Microcap Investor Conference
PR Newswire - Thu Feb 05, 8:17AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the SeeThruEquity ("STE" Winter Microcap Investor Conference this week in New York City. Mr. Schumacher's presentation at STE is scheduled for Thursday, February 5 at 11:00am at the Convene Times Square (810 Seventh Avenue).

Pressure BioSciences, Inc. Provides Update on Recent Equity Transactions
PR Newswire - Wed Jan 21, 8:31AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" (http://www.pressurebiosciences.com), a leader in the design, development and sale of pressure-based instruments and consumables for the biological research market worldwide, today provided an update on two recent equity transactions totaling $1,166,000.

Pressure BioSciences, Inc. to Present at the 8th Annual OneMedForum Investor Conference - San Francisco
PR Newswire - Mon Jan 12, 7:31AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 8th Annual OneMedForum Investor Conference in San Francisco, CA on Monday, January 12th at 12pm PST. The Investor Conference is being held at the San Francisco Marriott Marquis.

PharMerica Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:30AM CST
On Jan 2, 2015, Zacks Investment Research upgraded PharMerica Corp. (PMC) to a Zacks Rank #1 (Strong Buy)
PMC: 29.75 (-0.19), OCR: 92.51 (+0.70), AFAM: 38.81 (+0.93)

S&P Capital IQ Initiates Coverage on Pressure BioSciences, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Wed Dec 17, 9:35AM CST
S&P Capital IQ (MHFI) announced today that it has commenced Standard & Poor's Factual Stock Report coverage on Pressure BioSciences Inc. (OTCQB: PBIO).
MHFI: 105.70 (-0.10)

Pressure BioSciences Inc., (OTCQB: PBIO), Exclusive Interview for Interlinked's Investment News Channel at FSXinterlinked Investment Conference
PRWeb - Fri Dec 12, 6:02AM CST
Pressure BioSciences Inc., (OTCQB: PBIO), Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference.

Pressure BioSciences Ships Third Barozyme HT48 System
PR Newswire - Wed Dec 10, 9:38AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the commencement of the third independent evaluation of its new Barozyme HT48 high-throughput system. The evaluation will take place in the laboratory of Dr. William E. Funk of the Feinberg School of Medicine at Northwestern University. The Funk Laboratory focuses on developing and applying biomarker methods to explore environmental risk factors associated with chronic diseases, cancers, and other complex disorders. The Funk Laboratory is a current customer of the Company's patented pressure cycling technology ("PCT" instrument and consumable products.

Pressure BioSciences Ships First Two Barozyme HT48 Systems
PR Newswire - Tue Nov 18, 7:25AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the installation of its first two Barozyme HT-48 high throughput systems for independent evaluation and subsequent potential sale. One system was placed in the laboratory of Dr. Radoslav Goldman of Georgetown University while the other was placed in the laboratory of a leading biotechnology company. In both settings, the Company believes the new systems will deliver important and unique capabilities for the analysis and characterization of biological samples. Both groups are current customers of the Company's patented pressure cycling technology ("PCT" -based products.

Pressure BioSciences, Inc. to Host Third Quarter 2014 Earnings Conference Call on Tuesday, November 18, 2014
ACCESSWIRE - Mon Nov 17, 3:05PM CST
SOUTH EASTON, MA / ACCESSWIRE / November 17, 2014 / Pressure BioSciences, Inc. (OTCQB BIO) will host a conference call to discuss the results of the third quarter 2014, to be held Tuesday, November 18, 2014 at 4:30 PM Eastern Time.

Pressure BioSciences, Inc. Reports Third Quarter 2014 Financial Results and Provides Business Update
PR Newswire - Mon Nov 17, 8:42AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the three and nine-month periods ended September 30, 2014, which included record products and services revenue compared to any prior nine-month period. The Company also provided a business update.

Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform
PR Newswire - Mon Oct 27, 6:50AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" , a worldwide leader in the development and sale of high pressure-based sample preparation systems to the life sciences research market, today announced that Professor Ruedi Aebersold and his team presented a novel, accurate, highly reproducible, and robust method to allow - for the first time - routine high-throughput protein analysis on small needle biopsy samples by mass spectrometry (generally the method of choice for high-throughput protein analysis) within 12 hours. The method combines PBI's patented pressure cycling technology ("PCT" sample preparation platform with the novel SWATH mass spectrometry method developed by Dr. Aebersold's group in collaboration with AB SCIEX. Professor Aebersold and his team discussed their findings in several well-attended presentations at the 13th Human Proteome Organization World Congress, held October 5-8, in Madrid, Spain.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 0

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 44

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 74

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 165

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
PepsiCo Nears Deforestation-Free Sourcing Milestone by 2025

Updated Category News Views 34

PepsiCo's Aim for a Greener Supply Chain Well, look who's climbing the environmental ladder—PepsiCo. They’ve apparently hit 94% deforestation-free sourcing for those high-stakes commodities their empire relies on. Maybe it's a wake-up call for the rest of 'em still smogging about. The endgame? Full-fledged deforestation-free sourcing by 2030. That’s no walk in the...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 159

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 57

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 42

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading

Top 5 Most Recently Viewed Articles

Swinerton Strengthens Leadership in Design-Build Initiatives

Updated Category News Views 250

Swinerton Welcomes Jason Bone as New Design-Build Leader In an exciting development, Swinerton Incorporated has bolstered its design-build leadership by appointing Jason Bone as the Director of National Design-Build. With this strategic move, the company reaffirms its dedication to providing exceptional client experiences while adapting to the evolving demands of the...

Continue Reading
PayPoint plc Announces PDMR Shareholding Updates

Updated Category News Views 144

PayPoint plc PDMR Share Acquisitions The company, PayPoint plc, recently shared exciting news regarding the shareholdings of its key executives, known as Persons Discharging Managerial Responsibilities (PDMRs). These PDMRs are significant players in the company, including its Executive Directors, and they participate in the Share Incentive Plan (SIP) designed to encourage...

Continue Reading
UMH Properties Announces First Quarter 2025 Financial Insights

Updated Category News Views 349

UMH Properties Reports Strong First Quarter Results for 2025 UMH Properties, Inc. (NYSE: UMH) recently revealed its financial results for the first quarter of 2025, showcasing encouraging growth and improvement in various operational metrics. The company reported a total income of $61.2 million for the quarter ending March 31, 2025, reflecting a 6% increase compared to...

Continue Reading
Netcompany Group Launches Share Buyback to Enhance Value

Updated Category News Views 245

Share Buyback Program Update from Netcompany Group Company announcement No. 20/2025 1 September 2025 On 14 August 2025, Netcompany Group A/S announced the initiation of a share buyback program of up to DKK 500 million, aiming to repurchase a total of 3,700,000 shares. This strategic move is designed to adjust the company’s capital structure while also fulfilling...

Continue Reading
Marex Group Investors: Join the Securities Fraud Class Action

Updated Category News Views 190

Recent Class Action Notice for Marex Group plc Investors In a significant announcement, a class action lawsuit has been filed that could impact many investors in Marex Group plc (NASDAQ: MRX). This legal action arises from reports that raise serious allegations regarding the company's financial reporting practices. For those who bought Marex shares, this is a crucial time...

Continue Reading